RecruitingNot ApplicableNCT07033104
Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section
Analgesic Effect of Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section, A Prospective Randomized Study
Sponsor
Tanta University
Enrollment
70 participants
Start Date
Apr 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block
Eligibility
Sex: FEMALE
Inclusion Criteria1
- female pt ASA2 scheduled for cs under spinal anesthesia
Exclusion Criteria1
- patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERus guided Transversalis fascia plane block
addition of calcitonin to pubivacaine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07033104